BioNTech (BNTX)
(Delayed Data from NSDQ)
$113.05 USD
+0.77 (0.69%)
Updated Sep 23, 2024 03:53 PM ET
After-Market: $115.50 +2.45 (2.17%) 5:00 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 1 - 20 ( 165 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 091624
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Combo Flu / COVID-19 Vaccine Setback; 2Q24 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Topline BNT111 Results Announced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT324 Receives Fast Track Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
mRNA Vaccine Field Continues to Evolve; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Acasunlimab and BNT326 Results Presented at ASCO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
CEPI Commits to Funding Expanded African Vaccine Production; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Variants Unlikely to Drive Vaccinations; ADC License; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Moderna Patent Upheld in Europe; ASCO Clinical Data Overview; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Numerous Near-Term Data Catalysts; 1Q24 Financials; Modulating PT to $113
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key Takeaway From Biotech Breakthroughs Oncology Event: The Rise of PRAME-Targeted Therapies
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT122 Elicits Long-Term Responses; Patent Lawsuit Paused; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Collaboration Inked With Autolus, Expanding Manufacturing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 2124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
First Patient Dosed in BNT323 Phase 3 Trial; Lowering PT to $107
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 11124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 1124
Provider: Stock Traders Daily
Analyst: Research Department